Home > Journals > The Journal of Cardiovascular Surgery > Past Issues > The Journal of Cardiovascular Surgery 2018 April;59(2) > The Journal of Cardiovascular Surgery 2018 April;59(2):158-63

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as

 

REVIEW  LATEST ADVANCES IN TREATING FEMOROPOPLITEAL DISEASE 

The Journal of Cardiovascular Surgery 2018 April;59(2):158-63

DOI: 10.23736/S0021-9509.18.10374-0

Copyright © 2018 EDIZIONI MINERVA MEDICA

language: English

Treating complex femoropopliteal lesions

Rozemarijn J. van der VIJVER-COPPEN , Yannick W. ’t MANNETJE, Theo P. MENTING, Jan-Willem LARDENOIJE, Michel P. REIJNEN

Department of Vascular Sugery, Rijnstate Hospital, Arnhem, The Netherlands


PDF


Peripheral artery disease affects 202 million patients worldwide and may cause disabling intermittent claudication and critical limb ischemia. Next to life style changes, best medical treatment and supervised exercise therapy, it can be necessary to re-vascularize the limb. Treatment of femoropopliteal lesions poses a challenge and a surgical bypass remains recommended in the guidelines for longer and more complex lesions. Bypass surgery is associated with substantial morbidity and even mortality. Endovascular alternatives are quickly evolving from plain balloon angioplasty to drug-eluting stents, drug-coated balloons, polytetrafluoroethylene-covered stents and atherectomy. These developments might challenge the gold standard in the near future. This article focuses on which technique can be used for which femoropopliteal lesion, particularly complex lesions, and summarizes the most recent and important literature on this topic.


KEY WORDS: Endovascular procedures - Peripheral arterial disease - Cardiovascular diseases

top of page